Yang, Z., Meng, R., Ge, J., Xiao, C., Huang, R., Bai, J., Liu, H., Zhao, J., Zhang, L., Cao, X., Wang, X. (2026). A response-adapted and genomically informed strategy to optimize neoadjuvant chemotherapy versus endocrine therapy plus CDK4/6 inhibition in high-risk HR+/HER2− breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.591